Breaking News


Breaking News

Hadassah Appoints New Emergency Room Director

Dr. Ahmed Naama was appointed the new director of the Emergency Medicine Department (Emergency Room) at Hadassah Ein Kerem Hospital, Jerusalem, Israel.

Naama, an expert in emergency medicine and the management of acute emergencies and trauma, replaced Prof. Kobi Assaf, who was appointed as the director of the emergency medicine unit at the Hadassah Medical Center.

“Dr. Naama will lead the emergency medicine department with excellence and dedication,” said Prof. Yoram Weiss, CEO of Hadassah Hospital.

Dr. Naama completed his internship and residency in emergency medicine at Hadassah Ein Kerem Hospital. In 2018, he went on to specialize in the management of acute emergencies, trauma and ultrasound, at the Royal Melbourne Hospital in Australia. On his return to Israel, Dr. Naama was appointed director of the emergency medicine unit at Hadassah Ein Kerem Hospital and was recently appointed director of the department.

“The emergency medicine department is a challenging and complex place where every day is different,” said Dr. Naama.

Israeli Humanitarian Aid Delegation Departs for Türkiye

‘We’ll do our best to save lives’: IDF rescue delegation arrives in southern Turkey

150 search, rescue and medical experts getting to work after survey team scanned areas affected by deadly earthquake; IDF Medical Corps prepares to establish field hospital.

A delegation of 150 military rescue experts arrived in southern Turkey early Tuesday, as the country grappled with the aftermath of a devastating earthquake that killed thousands of people in the region. An initial, smaller team had flown in on Monday.

The Israel Defense Forces released photos of the team and supplies loading onto a plane at Israel’s Nevatim airbase, and landing in the Turkish city of Adana pre-dawn, and said the search and rescue operation would begin immediately.

Hours ahead of the flight, the head of the Israel Defense Forces aid delegation, Col. (Res.) Golan Vach, spoke to reporters about the mission.

“Some 150 rescue experts are prepared to leave for Turkey in the next few hours. Of these, a third are headquarters and intelligence, and two-thirds have rescue, medical, and engineering capabilities,” said Vach, who is the commander of the IDF National Rescue Unit and a former officer in the IDF Home Front Command.

Vach said it was the unit’s 31st expedition in the past 40 years. “We feel a great privilege to reach out to our neighbors and [their] citizens,” he said.

He said the powerful 7.8-magnitude earthquake and the secondary 7.5-magnitude quake that rocked the same area in southeastern Turkey and northern Syria was a “disaster on a large scale.”

“The most significant earthquake that [we went to] was in Haiti. Since then, there have been no earthquakes of this magnitude,” Vach said.

“We will do our best to save lives and help the Turkish people,” he added.

The aid delegation of Home Front Command officers — mostly reservists — and several Fire and Rescue Service officials departed after midnight on Tuesday, “and upon landing, will immediately begin the rescue and assistance mission,” the IDF said in a statement.

The IDF said the delegation — which landed in the city of Adana — was prepared for the harsh winter weather too. It was expected to operate in the Adana and Gaziantep areas.

On Monday afternoon, a small search and rescue team departed for Turkey to survey the area to get an initial picture of the situation on the ground, before the larger delegation headed in.

The Foreign Ministry was weighing a third flight containing humanitarian items and medicine.

Defense Minister Yoav Gallant meanwhile approved the IDF to establish a field hospital in Turkey, according to the needs of Turkish authorities, his office said.

Earlier Monday, the IDF said the Medical Corps was preparing to send a delegation that would establish a field hospital in the affected area.

Gallant held an assessment with IDF chief Herzi Halevi on Monday night, during which they discussed the military aid to Turkey and approving the field hospital, his office said.

Hebrew-language media reports suggested a field hospital delegation may depart for Turkey as early as Tuesday evening.

The military has dubbed the operation, “Olive Branches.”

The IDF Home Front Command is regularly dispatched around the world to assist in natural disasters, including earthquakes, wildfires, flooding, and building collapses. A team sent to Surfside, Florida, in 2021, helped head up rescue efforts at a deadly condo collapse.

Prime Minister Benjamin Netanyahu said earlier Monday that Israel also plans to send aid to Syria, including tents, medication, and blankets.

Israel considers Syria a hostile state, and the two do not have diplomatic ties. However, during the neighboring country’s bloody civil war, the IDF carried out a massive humanitarian operation to aid Syrian civilians.

But Syrian sources vigorously denied requesting aid from Israel, and IDF spokesman Ran Kochav told reporters that the military was not involved in potential aid to Syria.

Earlier Monday, President Isaac Herzog spoke with Turkish leader Recep Tayyip Erdogan to offer Israel’s condolences on the losses suffered in the deadly earthquake.

Herzog briefed Erdogan on the assistance Israel was sending, and told him that he met earlier in the day with Prime Minister Benjamin Netanyahu and opposition leader Yair Lapid and that they assured him the country is united in its desire to help Turkey, the president’s office said.

Erdogan thanked Herzog and expressed his appreciation that Israel was willing to stand with Turkey in its hour of difficulty, it said.

Erdogan also sent his deepest condolences for the terror attack that killed seven Israelis in East Jerusalem last month, the statement added.

Herzog was instrumental in restoring ties between Jerusalem and Ankara last year.

Also on Monday evening, the Tel Aviv municipality building was lit up in the colors of Turkey’s flag in an expression of solidarity with the victims.

The earthquake death toll was at least 4,300 people in both Turkey and Syria as of early Tuesday. Hundreds were still believed to be trapped under rubble, and the toll was expected to rise, as rescue workers searched mounds of wreckage in cities and towns across the area.

The quake was also felt by some residents of Israel, although there was no damage reported.


Times of Israel staff and agencies contributed to this report.

Hadassah Hospital medical staff have joined this operation

Much success to the Hadassah doctors who were called to the flag and left as part of the Israeli delegation to establish a field hospital in Turkey.

 “We are going on a mission for Hadassah and the State of Israel to help as much as possible to the wounded in the field and to give of ourselves wherever we are needed,” they said with their cheers.

The team included:

Dr. Mark Romain, Senior Physician in the Intensive Care Unit, Specialist in Nephrology and Anesthesia, Dr. Yuval Maroz, Specialist in Anesthesia, Dr. Avraham Alpert, Specialist in Emergency Medicine and Dr. Itai Bezel, a pediatrician.

Visit the IDF homepage for more information

Prof. Polina Stepensky Explains The CAR (Chimeric Antigen Receptor) T-Cell Therapy.

Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the Commercialization arm of Bar-Ilan University announced today that they have entered into the research and license agreement with Immix BioPharma, for the development and commercialization of novel tissue specific therapeutics based on anti-BCMA CAR-T cells targeting plasma cell. This technology has been developed as the result of a collaboration between Prof. Polina Stepensky, of Hadassah Medical Center, Jerusalem and Prof. Cyrille J. Cohen, of Bar-Ilan University, Ramat Gan. Dr. Shlomit Kfir-Erenfeld and Dr. Nathalie Asherie, of Hadassah Medical Center, and Ortal Harush, of Bar-Ilan University, also participated in the research.

For more information visit Yahoo! Finance

Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating Symptoms

Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating Symptoms

Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients. 

Millions of Americans of all ages suffer from post-COVID-19 condition, or long COVID. In fact, recent datashow that the condition is affecting more than 16 million working-age Americans and is keeping between two and four million of them out of work completely. 

According to the World Health Organization, long COVID occurs when an individual continues to suffer from prolonged symptoms of the virus at least 3 months after initial onset. Common symptoms include difficulty thinking or concentrating, sleep trouble, dizziness, headaches, fatigue, brain fog and more. In many cases, these symptoms prove to be debilitating and result in significant health and quality of life issues.

Health care professionals around the globe are working tirelessly to understand, diagnose. and treat long COVID. While there is no single treatment that has been approved to completely rid those with long COVID of their symptoms, a growing body of clinical research supports the potential of a specific hyperbaric oxygen therapy (HBOT) protocol to become part of the standard of care for the condition. A breakthrough randomized controlled trial on use of the protocol for symptom management was published in Scientific Reports in July.

The study was conducted by the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center in Israel, known for its pioneering research on novel indications of hyperbaric medicine for cognitive and physical rehabilitation. The cohort was comprised of 73 participants with reported long COVID cognitive symptoms. To study the effectiveness of the HBOT protocol in treating these individuals, patients were randomly assigned to either a treatment or placebo (sham) group. The unique treatment protocol was comprised of 40 daily HBOT sessions, 5 sessions per week. 

The randomized, double-blind, placebo-controlled clinical trial demonstrated that HBOT, when used in a specific protocol was effective at improving symptoms of long COVID. Participants showed significant improvement in global cognitive function, energy, sleep, psychiatric symptoms, and pain interference. Participants in the control group did not exhibit these same improvements. 

The study revealed that HBOT can induce structural and functional repair of damaged regions of the brain and improve cognitive, behavioral, and emotional function of patients with long COVID conditions.

Further analysis of the brain network activity of those patients was published in the journal Neuroimage: Clinical and shed additionallight on how COVID can disrupt the normal functionality of the brain. Moreover, the study shows that in post-COVID-19 patients, HBOT improves disruptions observed in white matter tracts (neuronal fibers) and alters the functional connectivity organization of neural pathways attributed to cognitive and emotional recovery.

While HBOT has been used for centuries, this new study indicates that utilizing a specific protocol involving oxygen fluctuation in a multiplace chamber can induce neurogenesis, neuronal stem cell proliferation, increased blood flow, and neuroplasticity. HBOT involves breathing 100% pure oxygen while in a controlled hyperbaric chamber. The air pressure inside is elevated above normal to help the lungs collect more oxygen and more effectively deliver that oxygen to damaged tissues, thus expediting the healing process. Deliberate fluctuations of oxygen levels during each HBOT session work to induce the hypoxia inducible factor, increasing vascularization and promoting angiogenesis in damaged brain tissues. 

The specific HBOT protocol studied here is in use for treatment of the symptoms of long COVID at Aviv Clinics through an exclusive partnership with the Sagol Center. The partnership allows Aviv clinics in Florida and Dubai to use the protocols, evaluation methods, and treatments used in the Scientific Reports study. Patient assessment includes high resolution brain imaging to identify damage in the brain caused by the SARS-CoV-2 virus. When combined with the results of intensive cognitive, physical, and nutritional assessments, these scans allow a multidisciplinary team of clinicians to develop a customized treatment program to help each patient.

Shai Efrati, MD, is founder and director of the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, Be’er Ya’akov, Israel, where he also serves as director of research and development and head of nephrology. Efrati’s research focuses on novel aspects of hyperbaric medicine and brain rehabilitation. He is a professor at the Sackler School of Medicine and the Sagol School of Neuroscience in Tel Aviv University. Since 2008, he has served as Chairman of the Israeli Society for Diving and Hyperbaric Medicine.

By Shai Efrati, MD

View original article in Patient Care 

Image: Times of Israel

Can't Find What You're Looking For?